Xeltis' aXess Vascular Graft Development Receives Funding From European ...
Xeltis secured €12.5M from EIC Fund, totaling €44.5M raised. Funds will advance clinical trials for aXess vascular graft for chronic kidney disease patients and coronary artery bypass graft program, utilizing a polymer implant that regenerates patient's tissue.
Reference News
Xeltis' aXess Vascular Graft Development Receives Funding From European ...
Xeltis secured €12.5M from EIC Fund, totaling €44.5M raised. Funds will advance clinical trials for aXess vascular graft for chronic kidney disease patients and coronary artery bypass graft program, utilizing a polymer implant that regenerates patient's tissue.